Transforming medical devices for improved patient outcomes

Scientific Advisors

Elazer R. Edelman, M.D., Ph.D.
Thomas D. and Virginia W. Cabot Professor of Health Sciences and Technology, MIT
Attending Cardiologist, Brigham and Women’s Hospital
Director, Harvard – MIT Biomedical Engineering Center (BMEC)

David E. Kandzari, M.D.
Director, Interventional Cardiology and Research, Piedmont Heart Institute
Former CMO, Johnson & Johnson’s Cordis Cardiology Unit
Former Medical Officer, FDA’s Center for Devices and Radiological Health

Peter J. Fitzgerald, M.D., Ph.D.
Professor of Medicine & Engineering, Stanford University Medical Center
Director, Interventional Cardiology Research Lab, Stanford Medical School
Director, Center for Cardiovascular Technology, Stanford University
Director, Cardiovascular Core Analysis Laboratory, Stanford Medical School

Martin B. Leon, M.D.
Founder and Chairman Emeritus, Cardiovascular Research Foundation
Professor of Medicine, Columbia University College of Physicians and Surgeons
Associate Director, Center for Interventional Vascular Therapy, New York-Presbyterian Hospital/Columbia University Medical Center

Patrick Serruys, M.D., Ph.D.
Chief of Interventional Cardiology, Thoraxcenter-Erasmus University, Rotterdam, The Netherlands
Co-Founder and Board Member of EuroPCR, Paris, France

William Wijns, M.D., Ph.D.
Principal Investigator, Micell’s DESSOLVE I and DESSOLVE II Clinical Trials
Co-Director, Cardiovascular Center, Aalst, Belgium

Co-Director, EuroPCR, Paris, France
Chairman, PCR